Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Arcus Biosciences, Inc.
Universidade Federal de Pernambuco
Shenzhen BinDeBio Ltd.
M.D. Anderson Cancer Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca